Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 6,620 | 8,640 | 9,340 | 10,170 | 8,550 |
| Operating Income | -6,620 | -8,640 | -9,340 | -10,170 | -8,550 |
| Other Income | 70 | 70 | 70 | 90 | 110 |
| Pre-tax Income | -6,550 | -8,570 | -9,270 | -10,080 | -8,440 |
| Income Tax | 0 | 23 | 10 | -3 | 0 |
| Net Income Continuous | -6,596 | -8,271 | -9,314 | -10,161 | -8,421 |
| Net Income | $-6,596 | $-8,271 | $-9,314 | $-10,161 | $-8,421 |
| EPS Basic Total Ops | -0.76 | -1.04 | -1.14 | -1.23 | -1.04 |
| EPS Basic Continuous Ops | -0.79 | -1.02 | -1.15 | -1.26 | -1.07 |
| EPS Diluted Total Ops | -0.76 | -1.04 | -1.14 | -1.23 | -1.04 |
| EPS Diluted Continuous Ops | -0.79 | -1.02 | -1.15 | -1.26 | -1.07 |
| EBITDA(a) | $-6,600 | $-8,620 | $-9,310 | $-10,140 | $-8,530 |